Urine scRNAseq reveals new insights into the bladder tumor immune microenvironmentJOURNAL OF EXPERIMENTAL MEDICINEIF10.62024-06-071PRE
miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+T cell infiltrationMOLECULAR THERAPY ONCOLYTICSIF5.32023-12-018OAAI
Exploring Teslasuit's Potential in Detecting Sequential Slip-Induced Kinematic Changes among Healthy Young AdultsSENSORSIF3.52023-07-090OAAI
A concerted mechanism involving ACAT and SREBPs by which oxysterols deplete accessible cholesterol to restrict microbial infectionELIFEIF02023-01-2512OA
DISSECTING MYELOID CELL-MEDIATED MECHANISMS OF RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE IN BLADDER CANCERJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
Characterization of urine-derived immune cells from bladder cancer patients and comparison to tumor and peripheral bloodJOURNAL OF IMMUNOLOGYIF3.42022-05-011PRE
EXHAUSTED T CELL PHENOTYPES DEPEND ON TCR SIGNAL STRENGTHNATURE REVIEWS IMMUNOLOGYIF60.92022-02-225PRE
NKG2A AND HLA-E DEFINE A NOVEL MECHANISM OF RESISTANCE TO IMMUNOTHERAPY WITH M. BOVIS BCG IN NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-101OA
Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translationJOURNAL OF CONTROLLED RELEASEIF11.52020-11-0146PREAI
Cardiac Rehabilitation Availability and Delivery in Canada: How Does It Compare With Other High-Income Countries?CANADIAN JOURNAL OF CARDIOLOGYIF5.32018-10-0123PREAI
FABP4 as a key determinant of metastatic potential of ovarian cancerNATURE COMMUNICATIONSIF15.72018-07-26177OAAI
TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signallingSCIENTIFIC REPORTSIF3.92016-11-2364OAAI